Diretriz da AHA: Nos tratamentos de câncer de mama e de próstata que incluem hormonioterapias, é necessário um controle mais rígido do risco cardíaco
29 Abr, 2021 | 10:12hComunicado de Imprensa: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association
Principais tópicos: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association
Comentários: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association E Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association E Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD E Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay